ThinkstockHealth care has been a top sector for investors this year. The research team at Oppenheimer continues to believe that health care remains well positioned to deliver further market-topping returns in 2014. Earnings revisions…
ThinkstockHorizon Pharma Inc. (NASDAQ: HZNP) is having a stellar day after breaking news that it entered into a pact with AstraZeneca PLC (NYSE: AZN) for the U.S. rights to VIMOVO. The move aims to…
ThinkstockThe market for pharmaceuticals and biotech drugs just keeps growing. The so-called patent cliff may be affecting Big Pharma companies locally, but a new report from IMS Health shows that the total spending on…
ThinkstockSkin cancer treatments remain elusive. While some drugs are on the market for advanced-stage treatment, the most common and longest method of initial treatment still involves the doctor taking the scalpel and cutting it…
Healthcare.govCovering the implementation of the Affordable Care Act has been no easy matter and it is a topic that is hard to not draw fire from one side or another. Many Americans are against…
thinkstockAmerican’s have become sick of the federal health care exchange site. It happened so quickly, as a matter of fact, that they now worry about health care as the country’s most severe problem. Next…
Healthcare.govThe Affordable Care Act is becoming more and more of a misnomer each day, and its broad appeal is running far less than the White House hoped for. Monumental sign-up delays and website glitches…
ThinkstockDendreon Corp. (NASDAQ: DNDN) has been down and out, and now the company is going to try a restructuring strategy after earnings, in an effort to save it from the worst case scenario. The…
ThinkstockThe wave of mergers and acquisitions in health care continues with two big announcements Monday. Drug maker Shire PLC (NASDAQ: SHPG) will acquire the rare disease biopharmaceutical company ViroPharma (NASDAQ: VPHM) in a deal…
ThinkstockSeeing Geron Corporation (NASDAQ: GERN) as one of the top gaining stories on the day brought back memories of when this company was the leader in stem cells. That was then, and trust of…
ThinkstockThe administration has basically admitted that the rollout and launch of the Affordable Care Act, or Obamacare, has been nothing short of a disaster so far. The website was never prepared to handle the…
ThinkstockAs part of it ongoing efforts to trim down by shedding weaker brands, Swiss food giant Nestle has announced that it will sell most of its Jenny Craig unit to private equity firm North…
ThinkstockBiotech and certain aspects of the health care and life sciences sector can often see incredible surges from day to day. The group can also witness many implosions on bad news as well. 24/7…
Wikimedia CommonsJohnson & Johnson (NYSE: JNJ) is facing a serious settlement charge-off that is somehow a victory for shareholders. J&J has had many quality control issues in recent years, but the company and the…
ThinkstockIdenix Pharmaceuticals Inc. (NASDAQ: IDIX) was the biggest gainer of all listed stocks on Friday with a rally of 40%. Its trading volume of almost 9.2 million shares was almost eight-times the normal volume.…